Somite.ai Taps AMD to Turbocharge Foundation Models for Cell Therapy
Somite.ai, a biotech startup building foundation models for human stem cells, has landed a strategic investment from AMD Ventures. The deal follows Somite’s $47 million Series A raise in May, led by Khosla Ventures, and adds serious compute firepower to the company’s mission: using large-scale AI to transform the way cell therapies are discovered and developed.
